CORCEPT THERAPEUTICS INC Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Corcept Therapeutics Inc quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Corcept Therapeutics Inc Operating Lease, Payments for the quarter ending June 30, 2024 was $741K, a 28.2% increase year-over-year.
  • Corcept Therapeutics Inc Operating Lease, Payments for the twelve months ending June 30, 2024 was $2.59M, a 12.1% increase year-over-year.
  • Corcept Therapeutics Inc annual Operating Lease, Payments for 2023 was $2.39M, a 5.56% increase from 2022.
  • Corcept Therapeutics Inc annual Operating Lease, Payments for 2022 was $2.27M, a 7.65% increase from 2021.
  • Corcept Therapeutics Inc annual Operating Lease, Payments for 2021 was $2.1M, a 14.3% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.39M +$126K +5.56% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $2.27M +$161K +7.65% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $2.1M +$264K +14.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $1.84M +$289K +18.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-15
2019 $1.55M Jan 1, 2019 Dec 31, 2019 10-K 2021-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.